234 related articles for article (PubMed ID: 22429650)
1. Metabolomics in cancer: a bench-to-bedside intersection.
Claudino WM; Goncalves PH; di Leo A; Philip PA; Sarkar FH
Crit Rev Oncol Hematol; 2012 Oct; 84(1):1-7. PubMed ID: 22429650
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics: available results, current research projects in breast cancer, and future applications.
Claudino WM; Quattrone A; Biganzoli L; Pestrin M; Bertini I; Di Leo A
J Clin Oncol; 2007 Jul; 25(19):2840-6. PubMed ID: 17502626
[TBL] [Abstract][Full Text] [Related]
3. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics and surgical oncology: Potential role for small molecule biomarkers.
Davis VW; Bathe OF; Schiller DE; Slupsky CM; Sawyer MB
J Surg Oncol; 2011 Apr; 103(5):451-9. PubMed ID: 21400531
[TBL] [Abstract][Full Text] [Related]
5. Cancer biomarkers: current issues and future directions.
Jain KK
Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
[TBL] [Abstract][Full Text] [Related]
6. New omics information for clinical trial utility in the primary setting.
Damia G; Broggini M; Marsoni S; Venturini S; Generali D
J Natl Cancer Inst Monogr; 2011; 2011(43):128-33. PubMed ID: 22043059
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics in paediatric oncology: a potential still to be exploited.
Spiga L; Atzori L; Noto A; Moretti C; Mussap M; Masile A; Lussu M; Fanos V
J Matern Fetal Neonatal Med; 2013 Oct; 26 Suppl 2():20-3. PubMed ID: 24059547
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics and cancer drug discovery: let the cells do the talking.
D'Alessandro A; Zolla L
Drug Discov Today; 2012 Jan; 17(1-2):3-9. PubMed ID: 22001601
[TBL] [Abstract][Full Text] [Related]
9. New science-based endpoints to accelerate oncology drug development.
Kelloff GJ; Sigman CC
Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
[TBL] [Abstract][Full Text] [Related]
10. Identification and elucidation of the biology of adverse events: the challenges of safety assessment and translational medicine.
Turteltaub KW; Davis MA; Burns-Naas LA; Lawton MP; Clark AM; Reynolds JA
Clin Cancer Res; 2011 Nov; 17(21):6641-5. PubMed ID: 22046025
[TBL] [Abstract][Full Text] [Related]
11. [OMICS and biomarkers of glial tumors].
Idbaih A
Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
[TBL] [Abstract][Full Text] [Related]
12. Improving the outcomes: developing cancer therapeutics.
Utku N
Future Oncol; 2012 Jan; 8(1):87-103. PubMed ID: 22149037
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research.
Rochfort S
J Nat Prod; 2005 Dec; 68(12):1813-20. PubMed ID: 16378385
[TBL] [Abstract][Full Text] [Related]
14. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
[TBL] [Abstract][Full Text] [Related]
15. Evolving 'omics' technologies for diagnostics of head and neck cancer.
Nagaraj NS
Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
[TBL] [Abstract][Full Text] [Related]
16. Qualification of imaging biomarkers for oncology drug development.
Waterton JC; Pylkkanen L
Eur J Cancer; 2012 Mar; 48(4):409-15. PubMed ID: 22226478
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
18. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics and fluxomics approaches.
Cascante M; Marin S
Essays Biochem; 2008; 45():67-81. PubMed ID: 18793124
[TBL] [Abstract][Full Text] [Related]
20. Challenges and opportunities for oncology biomarker discovery.
Deyati A; Younesi E; Hofmann-Apitius M; Novac N
Drug Discov Today; 2013 Jul; 18(13-14):614-24. PubMed ID: 23280501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
